drugset / Trial / NCT00314704

Dopamine and Norepinephrine in Shock Patients

NCT00314704

Phase 3 Completed 1679 enrolled Sepsis Occurrence in Acutely Ill Patients
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the efficacy of dopamine and norepinephrine, two commonly used vasopressor agents, in the treatment of shock.

Timeline

Start
2003-12
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dopamine Small molecule 20 ug/kg
Subject Norepinephrine Other / unclassified 0.19 ug/kg

Indications

No indication recorded.